跳至主要内容
临床试验/CTRI/2023/03/050477
CTRI/2023/03/050477尚未招募Unknown

COMPARISON OF ARTHROCENTESIS, INJECTABLE PLATELET RICH FIBRIN AND COMBINATION OF THE TWO IN PATIENTS WITH UNILATERAL TEMPOROMANDIBULAR JOINT INTERNAL DERANGEMENT: A RANDOMIZED CONTROLLED TRIA

I0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age: More than 18 years or less than or equal to 50 years.
  • Unilateral temporomandibular disorder (Wilkes II, III, IV)
  • Painful TMD
  • Occasional difficulty in mouth opening

排除标准

  • Age18 or less and more than 50
  • Pregnant female
  • Autoimmune diseases such as osteoarthritis and rheumatoid arthritis
  • Patient allergic to local anaesthesia
  • Patient in whom magnetic resonance imaging (MRI) is contraindicated
  • Patient with history of TMJ surgery
  • Patient with the congenital or developmental disorder of TMJ
  • Benign or malignant TMJ lesions
  • Patients refusing to attend all scheduled visits

研究者

发起方
I

相似试验